Literature DB >> 29317071

Recently discovered interstitial cells "telocytes" as players in the pathogenesis of uterine leiomyomas.

Ivan Varga1, Martin Klein2, Ladislav Urban3, Ludovit Danihel5, Stefan Polak2, Ludovit Danihel5.   

Abstract

Uterine telocytes are interstitial cells characterized by a very long cytoplasmic prolongations, which form a 3D network, functionally integrating a wide variety of different cells. Leiomyomas (uterine fibroids) are benign tumors, which pose a huge threat concerning various health problems in women affected by this condition. The exact cause of leiomyomas development is, however, still largely unknown. Therefore, in an attempt to clarify their etiology, we performed an immunohistochemical characterization of telocytes in leiomyomas as well as in normal myometrium. Tissue samples of intramural leiomyomas from 26 women (age 46.26 ± 11.07) were immunohistochemically stained for the expression of c-kit (CD117) antigen, one of the markers of telocytes. C-kit (CD117) antigen is useful for a routine immunohistochemical identification of uterine telocytes in histological sections of myometrium. In normal, healthy myometrium the c-kit positive telocytes occupy approximately 2.2% of the area of a tissue slide, contrasting with no detectable c-kit positive cells within leiomyomas. As telocytes are thought to be key players in the regulation of tissue homoeostasis, our data suggest that uterine telocyte loss may have important implications in the pathogenesis of leiomyomas. In addition, we supposed to summarize three hypotheses on the association of the cells telocytes loss within the myometrium and formation of leiomyomas. These hypotheses include the loss of telocytes' functions as "sex hormone sensors" and regulators of smooth muscle cells cycle; the role of telocytes as progenitor cells for the development of leiomyomas; and the hypothesis of decreased angiogenesis after telocytes' loss with subsequent hypoxia (as a key factor for leiomyomas development).
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Immunohistochemistry; Myometrium; Telocytes; Uterine fibroid

Mesh:

Substances:

Year:  2017        PMID: 29317071     DOI: 10.1016/j.mehy.2017.11.003

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  5 in total

1.  From TELOCYTES to TELOCYTOPATHIES. Do Recently Described Interstitial Cells Play a Role in Female Idiopathic Infertility?

Authors:  Martin Klein; Lenka Lapides; Denisa Fecmanova; Ivan Varga
Journal:  Medicina (Kaunas)       Date:  2020-12-11       Impact factor: 2.430

2.  Modulation of Telocytes in Women with Preeclampsia: A Prospective Comparative Study.

Authors:  Eman Elsayed Abu-Dief; Hoda M Elsayed; Esraa W Atia; Mohamed Abdel-Rahman; Mohamed Fawzy
Journal:  J Microsc Ultrastruct       Date:  2021-01-22

Review 3.  Telocytes in the Female Reproductive System: Up-to-Date Knowledge, Challenges and Possible Clinical Applications.

Authors:  Martin Klein; Mária Csöbönyeiová; Ľuboš Danišovič; Lenka Lapides; Ivan Varga
Journal:  Life (Basel)       Date:  2022-02-10

Review 4.  Telocytes in Fibrosis Diseases: From Current Findings to Future Clinical Perspectives.

Authors:  Xiao-Jiao Wei; Tian-Quan Chen; Xiao-Jun Yang
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.139

5.  Beta-Estradiol Regulates Voltage-Gated Calcium Channels and Estrogen Receptors in Telocytes from Human Myometrium.

Authors:  Adela Banciu; Daniel Dumitru Banciu; Cosmin Catalin Mustaciosu; Mihai Radu; Dragos Cretoiu; Junjie Xiao; Sanda Maria Cretoiu; Nicolae Suciu; Beatrice Mihaela Radu
Journal:  Int J Mol Sci       Date:  2018-05-09       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.